[Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab].

García-Vaca AO, Nava-Ramírez CI

Open source

DOI: 10.29262/ram.v72i3.1490
Published: 2025 Sep 30
Container: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.29262/ram.v72i3.1490,
  title = {[Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab].},
  author = {García-Vaca AO and Nava-Ramírez CI},
  year = {2025},
  journal = {Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)},
  doi = {10.29262/ram.v72i3.1490},
  url = {https://doi.org/10.29262/ram.v72i3.1490}
}

RIS

TY  - JOUR
TI  - [Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab].
AU  - García-Vaca AO
AU  - Nava-Ramírez CI
PY  - 2025
JO  - Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
DO  - 10.29262/ram.v72i3.1490
UR  - https://doi.org/10.29262/ram.v72i3.1490
ER  -

APA

AO, G., & CI, N. (2025). [Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab].. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993). https://doi.org/10.29262/ram.v72i3.1490

Source records

pubmed · retrieved 2026-09-25T12:18:59.394Z
europe-pmc · retrieved 2026-09-25T12:18:59.367Z
doaj · retrieved 2026-09-25T12:18:59.374Z